MCCULLOCH KEVIN (See Remarks) exercised options at XERIS BIOPHARMA HOLDINGS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 2 exercises
Filed: 3/16/2026ACC: 0002031695-26-000006
Officer· See Remarks
Since Mar 2026
0.00
Net shares
Net seller
$200.0K
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
48.90K acquired · 48.90K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+48.89K
Price / share
$4.09
Trade value
$199.98K
% of position
2.8%
3/12/2026
1.73M→1.78M
Common Stock
Direct
Shares
+4.00
Price / share
$3.94
Trade value
$15.76
% of position
0.0%
3/12/2026
1.78M→1.78M
Total
Net shares
+48.90K
Net value
$199.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/12/2026 | M · Option Exercise | +48.89K | $4.09 | $199.98K | 2.8% | 1.73M | 1.78M |
| Common Stock Direct | 3/12/2026 | M · Option Exercise | +4.00 | $3.94 | $15.76 | 0.0% | 1.78M | 1.78M |
| Total | +48.90K | $199.99K | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
48.89K shares
Shares
−48.89K
Strike price
4.09
Held after
43.77K
Exercisable
—
3/12/2026
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
4.00 shares
Shares
−4.00
Strike price
3.94
Held after
80K
Exercisable
—
3/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock48.89K shares | 3/12/2026 | M · Option Exercise | −48.89K | 4.09 | — | 43.77K |
| Stock Option (Right to Buy) Direct | Common Stock4.00 shares | 3/12/2026 | M · Option Exercise | −4.00 | 3.94 | — | 80K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned25K
Total
25K indirect25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25K | Indirect |
| Total | 25K | 25K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported